Coming and going: Some aspects of care for migrants with HIV in the UK

Journal of Infection

Volumn 57, Issue 1, 2008, Pages 11-15

  Anderson, Jane ^a  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Asylum; HIV; Migration

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; PROTEINASE INHIBITOR; RIFAMYCIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL SUSCEPTIBILITY; CULTURAL FACTOR; DRUG HYPERSENSITIVITY; EUROPE; EXPERIENCE; HEALTH CARE; HEALTH CARE NEED; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RATE; MIGRATION; MORTALITY; NATIONAL HEALTH SERVICE; NONHUMAN; POLITICS; POPULATION RESEARCH; POVERTY; PUBLIC HEALTH; REVIEW; SEROPREVALENCE; SOCIAL ASPECT; SUPERINFECTION; TRAVEL; TUBERCULOSIS; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; VIRUS REPLICATION; VIRUS STRAIN;

ANTI-HIV AGENTS; EMIGRATION AND IMMIGRATION; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; REFUGEES; VARIATION (GENETICS);

EID: 46149115363     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.05.002     Document Type: Review

References (62)

1. Taylor J. United Nations international migration and economic development. In: International Symposium on International Migration and development; 2006.
2. Hamers F., and Downs A.M. The changing face of the HIV epidemic in Western Europe: what are the implications for public health policies?. Lancet 364 9428 (2004) 83-94
3. Sinka K., Mortimer J., Evans B., and Morgan D. Impact of the HIV epidemic in sub-Saharan Africa on the pattern of HIV in the UK. AIDS 17 11 (2003) 1683-1690
4. Worth H. Unconditional hospitality: HIV, ethics and the refugee 'problem'. Bioethics 20 5 (2006) 223-232
5. Sales R. The deserving and the undeserving? Refugees, asylum seekers and welfare in Britain. Crit Soc Policy 22 (2002) 456-478
6. Dodds C., Keogh K., Chime O., Haruperi T., Nabulya B., Ssanyu Sseruma W., et al. Outsider status: stigma and discrimination experienced by gay men and African people with HIV (2004), Sigma Research, London
7. UNAIDS. HIV and refugees. Policy Brief (2007)
8. Health Protection Agency. Migrant Health: infectious diseases in non-UK born populations in England, Wales and Northern Ireland. A baseline report (2006), Health Protection Agency Centre for Infections, London
9. Burnett A., and Peel M. Health needs of asylum seekers and refugees. BMJ 322 7285 (2001) 544-547
10. Clark R.C., and Mytton J. Estimating infectious disease in UK asylum seekers and refugees: a systematic review of prevalence studies. J Public Health (Oxf) 29 4 (2007) 420-428
11. Home Office. Asylum statistics: fourth quarter 2007. United Kingdom. Available from: (2008). http://www.homeoffice.gov.uk/rds/pdfs08/asylumq407.pdf
12. Amnesty International UK. Down and out in London: the road to destitution for rejected asylum seekers (2006), Amnesty International UK, London
13. UK Border and Immigration Agency. Current support amounts; 2008.
14. Creighton S., Sethi G., Edwards S.G., and Miller R. Dispersal of HIV positive asylum seekers: national survey of UK healthcare providers. BMJ 329 7461 (2004) 322-323
15. National AIDS Trust. Immigration removal centre responses to HIV and aids: results of a survey of healthcare managers. NAT Discussion Paper. London; 2007.
16. Hobson C., Cox J., and Sagovsky N. Fit for purpose yet? (2008), Independent Asylum Commission, London
17. National AIDS Trust. HIV and the UK asylum pathway (2008), National AIDS Trust, London
18. National Health Service. National Health Service (charges to overseas visitors) (amendment) regulations; 2004.
19. Department of Health. Implementing the overseas visitors hospital charging regulations (21 April 2004)
20. Cole P. Healthcare and social justice: human rights and the national interest: migrants. J Med Ethics. 33 (2007) 269-272
21. Hamill M., McDonald L., Brook G., and Murphy S. Ethical and legal issues in caring for asylum seekers and refugees in the UK. Bull Med Ethics 203 (2004) 17-21
22. Hall P. Failed asylum seekers and health care. BMJ 333 7559 (2006) 109-110
23. House of Commons Health Committee. New developments in sexual health and HIV/AIDS policy. Third report of session 2004-05 (2005), House of Commons, London
24. Anderson J., and Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care 16 1 (2004) 95-105
25. Anderson J., Doyal L., and Apenteg P. 'I want to survive, I want to win, I want tomorrow' an exploratory study of African men living with HIV in London (2005), Terrence Higgins Trust, London
26. Ndirangu E.W., and Evans C. Experiences of African immigrant women living with HIV in the U.K.: implications for health professionals. J Immigr Minor Health (2008)
27. Elford J., Ibrahim F., Bukutu C., and Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr 47 4 (2008) 514-521
28. Doyal L., and Anderson J. 'My fear is to fall in love again.' how HIV-positive African women survive in London. Soc Sci Med 60 8 (2005) 1729-1738
29. Doyal L., Anderson J., and Apenteng P. I want to survive, I want to win, I want tomorrow: an exploratory study of African men living with HIV in London (2005), Homerton University Hospital NHS Foundation Trust, London
30. Paparini S, Doyal L, Anderson J. 'I count myself as being in a different world': African gay and bisexual men living with HIV in London. An Exploratory study. AIDS Care, in press.
31. Doyal L., Paparini S., and Anderson J. 'Elvis Died and I was Born': Black African Men Negotiating Same-Sex Desire in London. Sexualities 11 1-2 (2008) 171-192
32. Ridge D., Williams I., Anderson J., and Elford J. Like a prayer: the role of spirituality and religion for people living with HIV in the UK. Sociol Health Illn 30 3 (2008) 413-428
33. Green G., and Smith R. The psychosocial and health care needs of HIV-positive people in the United Kingdom: a review. HIV Med 5 Suppl. 1 (2004) 5-46
34. Trust. CNA. Poverty and HIV: findings from the Crusaid Hardship Fund. London; 2006.
35. Ibrahim F, Anderson J, Bukutu C, Elford J. Social and economical hardship among people living with HIV in London. HIV Medicine, in press.
36. Weatherburn P., Ssanyu-Sseruma W., Hickson F., McLean S., and Reid D. Project Nasah. An investigation into the HIV treatment information and other needs of African people with HIV resident in England (2003), Sigma Research, London
37. Kaufman J.S., and Cooper R.S. Race in epidemiology: new tools, old problems. Ann Epidemiol 18 2 (2008) 119-123
38. Burns F., and Fenton K.A. Access to HIV care among migrant Africans in Britain. What are the issues?. Psychol Health Med 11 1 (2006) 117-125
39. Koehn P.H. Medical encounters in Finnish reception centres: asylum-seeker and clinician perspectives. J Refugee Studies 18 (2005) 47-75
40. Quickfall J. Developing a model for culturally competent primary care nursing for asylum applicants and refugees in Scotland: a review of the literature. Divers Health Social Care 1 (2004) 53-64
41. Sub-CommitteeBritish HIV Association. BHIVA mortality audit (2006)
42. Sabin C., Smith C., Youle M., Lampe F., Robertson Bell D., Puradiredja D., et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS 20 1 (2006) 67-71
43. Boyd A., Murad S., O'shea S., de Ruiter A., Watson C., and Easterbrook P. Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med 6 2 (2005) 59-65
44. Chadborn T.R., Delpech V.C., Sabin C.A., Sinka K., and Evans B.G. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 20 18 (2006) 2371-2379
45. Burns F.M., Imrie J.Y., Nazroo J., Johnson A.M., and Fenton K.A. Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care 19 1 (2007) 102-108
46. Burns F.M., Johnson A.M., Nazroo J., Ainsworth J., Anderson J., Fakoya A., et al. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 22 1 (2008) 115-122
47. Cook P.A., Downing J., Rimmer P., Syed Q., and Bellis M.A. Treatment and care of HIV positive asylum seekers. J Epidemiol Community Health 60 10 (2006) 836-838
48. Elford J., Ibrahim F., Bukutu C., and Anderson J. Uptake of antiretroviral treatment among people living with HIV in London: ethnicity, gender and sexual orientation. Sex Transm Infect (2008)
49. Staehelin C., Rickenbach M., Low N., Egger M., Ledergerber B., Hirschel B., et al. Migrants from Sub-Saharan Africa in the Swiss HIV cohort study: access to antiretroviral therapy, disease progression and survival. AIDS 17 15 (2003) 2237-2244
50. Nellen J.F., Wit F.W., De Wolf F., Jurriaans S., Lange J.M., and Prins J.M. Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands. J Acquir Immune Defic Syndr (29-06-2004) 943-950
51. Dray-Spira R., Spire B., Heard I., and Lert F. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA study. AIDS 21 Suppl. 1 (2007) S5-S12
52. Battegay M., Fluckiger U., Hirschel B., and Furrer H. Late presentation of HIV-infected individuals. Antivir Ther 12 6 (2007) 841-851
53. Pozniak A.L., Miller R.F., Lipman M.C., Freedman A.R., Ormerod L.P., Johnson M.A., et al. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005. HIV Med 6 Suppl. 2 (2005) 62-83
54. Nelson M., Matthews G., Brook M.G., and Main J. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005). HIV Med 6 Suppl. 2 (2005) 96-106
55. Nyakutira C., Roshammar D., Chigutsa E., Chonzi P., Ashton M., Nhachi C., et al. High prevalence of the CYP2B6 516G{right triple arrow}T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe. Eur J Clin Pharmacol 64 4 (2008) 357-365
56. Williams I., and Churchill D. Management of advanced HIV disease with no other complications in women and in Africans. Int J Clin Pract 61 1 (2007) 119-129
57. Kiwanuka N., Laeyendecker O., Robb M., Kigozi G., Arroyo M., McCutchan F., et al. Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197 5 (2008) 707-713
58. Parkin N.T., and Schapiro J.M. Antiretroviral drug resistance in non-subtype B HIV-1, HIV-2 and SIV. Antivir Ther 9 1 (2004) 3-12
59. Spira S., Wainberg M.A., Loemba H., Turner D., and Brenner B.G. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 51 2 (2003) 229-240
60. Bannister W., Ruiz L., Loveday C., Vella S., Zilmer K., Kjær J., et al. HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir Ther 11 (2006) 707-715
61. De Wit S., Boulme R., Poll B., Schmit J.C., and Clumeck N. Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients. AIDS 18 17 (2004) 2330-2331
62. Sanches M., Krauchenco S., Martins N.H., Gustchina A., Wlodawer A., and Polikarpov I. Structural characterization of B and non-B subtypes of HIV-protease: insights into the natural susceptibility to drug resistance development. J Mol Biol 369 4 (2007) 1029-1040